Počet záznamů: 1  

Enhancement of immune response towards non-lipidized Borrelia burgdorferi recombinant OspC antigen by binding onto the surface of metallochelating nanoliposomes with entrapped lipophilic derivatives of norAbuMDP

  1. 1.
    SYSNO ASEP0379796
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevEnhancement of immune response towards non-lipidized Borrelia burgdorferi recombinant OspC antigen by binding onto the surface of metallochelating nanoliposomes with entrapped lipophilic derivatives of norAbuMDP
    Tvůrce(i) Křupka, M. (CZ)
    Mašek, J. (CZ)
    Bartheldyová, E. (CZ)
    Turánek Knotigová, P. (CZ)
    Plocková, J. (CZ)
    Korvasová, Z. (CZ)
    Škrabalová, M. (CZ)
    Koudelka, Š. (CZ)
    Kulich, P. (CZ)
    Zachová, K. (CZ)
    Czerneková, L. (CZ)
    Strouhal, O. (CZ)
    Horynová, M. (CZ)
    Šebela, M. (CZ)
    Miller, A. D. (GB)
    Ledvina, Miroslav (UOCHB-X) RID
    Raška, M. (CZ)
    Turánek, J. (CZ)
    Celkový počet autorů18
    Zdroj.dok.Journal of Controlled Release. - : Elsevier - ISSN 0168-3659
    Roč. 160, č. 2 (2012), s. 374-381
    Poč.str.8 s.
    Jazyk dok.eng - angličtina
    Země vyd.NL - Nizozemsko
    Klíč. slovaBorrelia burgdorferi ; OspC ; metallochelating liposomes ; MDP
    Vědní obor RIVCC - Organická chemie
    CEPGAP304/10/1951 GA ČR - Grantová agentura ČR
    TA01011165 GA TA ČR - Technologická agentura ČR
    KAN200520703 GA AV ČR - Akademie věd
    KAN200100801 GA AV ČR - Akademie věd
    CEZAV0Z40550506 - UOCHB-X (2005-2011)
    UT WOS000305788800033
    DOI10.1016/j.jconrel.2012.02.017
    AnotaceLyme disease caused by spirochete Borrelia burgdorferi sensu lato, is a tick-born illness. If the infection is not eliminated by the host immune system and/or antibiotics, it may further disseminate and cause severe chronic complications. The immune response to Borrelia is mediated by phagocytic cells and by Borrelia-specific complement-activating antibodies associated with Th1 cell activation. A new experimental vaccine was constructed using non-lipidized form of recombinant B. burgdorferi s.s. OspC protein was anchored by metallochelating bond onto the surface of nanoliposomes containing novel nonpyrogenic normuramyglycopeptides modified at carboxy terminus of the peptide part of their molecules by bulky lipophilic acyl residue. After i.d. immunization, the experimental vaccines surpassed Alum with respect to OspC-specific titers of IgG2a, IgG2b isotypes when analog modified with branch fatty acid was used and IgG3, IgM isotypes when analog modified with linear fatty acid was used. Both adjuvants exerted a high adjuvant effect comparable or better than MDP and proved themselves as nonpyrogenic.
    PracovištěÚstav organické chemie a biochemie
    Kontaktasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
    Rok sběru2013
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.